Prescription medication · Nasal Corticosteroid
mometasone nasal
Also sold as Nasonex. This medicine treats symptoms of hay fever and other upper respiratory allergies.
Data updated 2026-05-15
- $1.17
- Brand price (NADAC)
mometasone nasal (Nasonex) is a prescription Nasal Corticosteroid. This medicine treats symptoms of hay fever and other upper respiratory allergies.
Mometasone nasal spray helps relieve allergy symptoms. It is a nasal corticosteroid that reduces inflammation in the nose.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$1.17/unit
Generic Available
No
Pricing data from NADAC (CMS), effective September 18, 2024. Compare all drug costs →
What it does
This medicine treats symptoms of hay fever and other upper respiratory allergies.
Common side effects
No common side effects listed.
Key warnings
The growth rate of some children may be slower while using this product.
The sections below are summarized in plain English from mometasone nasal's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Mometasone is a type of medicine called a nasal corticosteroid. It works by reducing swelling and inflammation in your nose. This helps to relieve allergy symptoms.
Serious Warnings
The growth rate of some children may be slower while using this product. Children should use it for the shortest time needed to relieve symptoms. Talk to your child's doctor if they need to use the spray for more than two months a year.
Common Questions
How often should I use this spray?
How many sprays should I use?
Do I need to shake the bottle before using it?
Can children under 2 use this spray?
What should I do if my child needs to use the spray for a long time?
Do I need to sniff when I use the spray?
Where can I find detailed instructions on how to use the spray?
Is it okay to use more than the recommended dose to get better results?
Should an adult supervise the use of this spray in children?
Does this spray cure allergies?
What drug class is mometasone nasal?
Related Medications in Nasal Corticosteroid
Other drugs grouped near mometasone nasal - same-class peers and common alternatives.
azelastine
Astelin, Astepro
Azelastine nasal spray is an antihistamine medicine.
Compare with mometasone nasal →
budesonide nasal
Rhinocort
Rhinocort is a nasal spray that helps relieve allergy symptoms.
Compare with mometasone nasal →
cetirizine
Zyrtec
Cetirizine (Zyrtec) is an antihistamine medicine.
Compare with mometasone nasal →
chlorpheniramine
Chlor-Trimeton
Chlorpheniramine is an antihistamine medicine.
Compare with mometasone nasal →
ciclesonide nasal
Omnaris, Zetonna
Omnaris Nasal Spray is a medicine that helps treat allergy symptoms in your nose.
Compare with mometasone nasal →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on mometasone nasal
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for mometasone nasal
The FDA label for mometasone nasal (sold under brand names such as Nasonex) classifies it as a prescription-only medication in the Nasal Corticosteroid class. This medicine treats symptoms of hay fever and other upper respiratory allergies. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: August 19, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages